c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
about
Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications.Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis.Imatinib: a breakthrough of targeted therapy in cancer.Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.Gastrointestinal stromal tumor - an evolving concept.Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST).Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors.Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors.Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?Heterogeneity of kinase inhibitor resistance mechanisms in GISTMolecular characterization of pediatric gastrointestinal stromal tumors.Imatinib treatment for gastrointestinal stromal tumour (GIST).Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.Targeted therapy in GIST: in silico modeling for prediction of resistance.Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study.A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors.A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance.Mechanism of Resistance in Gastrointestinal Stromal Tumors.
P2860
Q30245586-B8CA2293-69CE-4EA7-9EA0-7732A5BC14AAQ33712862-8C2EA2B8-3D1A-435F-9455-CC81A36D67FFQ33747261-576A2A66-983A-4CAD-BDCF-DFF561255955Q34029127-701246A4-D2C2-440A-8CE2-5A28E5794200Q34928165-71C7E621-637F-4544-85FF-F2EA302E8AC3Q35273302-F51E097D-F5BB-4D03-85BB-E911851F2FEEQ36180074-F7AB7A16-A0E4-4199-BCA2-AFE83E7D76FCQ36925163-379C240D-0AB7-4E84-8824-EE8E8A087C13Q36970527-C36F4ADE-4CED-4947-A8C1-6A41C67F31A7Q37218711-B840CC99-58A0-49B4-BD5E-42C93A8FB46EQ37247100-0A1D11C6-DA41-4418-992B-13CF40C19C11Q37334993-E5DEC444-FCF6-4858-B1BA-9446D2EF1507Q37823438-34C0E55B-16FC-42AC-9A25-A53BBE20F853Q37848666-ABED2F99-3E63-49E6-89A1-F81895C8E68EQ38382493-022D8265-EA9E-453B-A218-87310B1CED9BQ46092027-AE887F0F-99D7-4C7A-8B3D-02C9910FB833Q46739137-9994F35E-E9E3-436B-A652-3521C1981859Q46783356-4ACF0BD2-3E7B-4CFC-8CA8-E9285429CEE4Q47329842-E565FFC1-834A-4479-A37E-1085160E5A98Q48599372-9A650BCF-868D-404B-96EC-6FC4BD274710
P2860
c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@en
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@nl
type
label
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@en
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@nl
prefLabel
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@en
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@nl
P2093
P50
P1476
c-Kit/PDGFRA gene status alter ...... strointestinal stromal tumors.
@en
P2093
Antonino Carbone
Francesca C Miselli
M Stefania Lagonigro
Marta Orsenigo
Paola Casieri
Silvana Pilotti
P304
P356
10.1158/1078-0432.CCR-06-1745
P407
P50
P577
2007-04-01T00:00:00Z